Dec 22, 2017   SOURCE: PR NewsWire

United States Off-pump Coronary Artery Bypass Devices Market Report 2017-2018

DUBLIN, Dec. 22, 2017 /PRNewswire/ --

The "US Market Report for Off-Pump Coronary Artery Bypass Devices 2018 - MedCore" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Off-pump coronary artery bypass (OPCAB), or simply beating-heart coronary artery bypass grafting, utilizes a medial sternotomy to access the heart, similarly to on-pump coronary artery bypass (ONCAB) procedures. The important difference is that the cardiopulmonary bypass pump is not employed. Clinical studies show that OPCAB offers several benefits compared to ONCAB procedures, including reductions in bleeding, decreases in short-term neurocognitive dysfunction, kidney dysfunction and length of hospital stay. Despite these advantages, the inherent technical challenges of performing OPCAB have impeded its widespread adoption.

These off-pump procedures require special techniques and instrumentation in order to perform efficient and reliable anastomosis on the beating heart. The increasing penetration of anastomosis assist devices (AAD) has helped to create precise and reliable anastomoses and slow the decline in OPCAB procedure volume. It should be noted that all minimally invasive coronary artery bypass graft (CABG) procedures, including minimally invasive direct coronary artery bypass (MIDCAB) and totally endoscopic coronary artery bypass (TECAB), are performed off-pump. These procedures differ from traditional OPCAB techniques in that they do not require a highly invasive medial sternotomy.

OPCAB procedures are much harder to perform because the beating heart adds difficulty in performing a bypass on the posterior and lateral walls of the heart. Surgeons have found many ways to stabilize the heart to bypass the necessary arteries. Most commonly, stabilizer and positioner devices are used in surgeries to aid physicians in stabilizing and positioning the heart and arteries.

Key Topics Covered:

Executive Summary

    --  U.S. Cardiac Surgery And Heart Valve Device Market Overview
    --  Competitive Analysis
    --  Market Trends
    --  Market Developments
    --  Procedure Numbers
    --  Procedure Codes Investigated
    --  Markets Included
    --  Key Report Updates
    --  Version History

1. Research Methodology

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Coronary Artery Disease
2.1.2 Myocardial Infarction
2.1.3 Angina Pectoris
2.1.4 Heart Valve Disease
2.1.5 Congestive Heart Failure

3. Product Portfolio
3.1.1 Tissue Heart Valves
3.1.2 Mechanical Tissue Heart Valves
3.1.3 Annuloplasty Repair Devices
3.1.4 Transcatheter Aortic Valve Replacement Devices
3.1.5 Transcatheter Mitral Valve Repair Devices
3.1.6 On-Pump Coronary Artery Bypass Devices
3.1.7 Off-Pump Coronary Artery Bypass Devices
3.1.8 Endoscopic Vessel Harvesting Devices
3.1.9 Anastomosis Assist Devices
3.1.10 Transmyocardial Revascularization Devices
3.1.11 Ventricular Assist Devices
3.1.12 Intra-Aortic Balloon Pump Device
3.1.13 Temporary Artificial Heart Replacement Device
3.1.14 Remote Hemodynamic Monitoring System Devices
3.1.15 Patent Foramen Ovale Devices
3.1.16 Atrial & Ventricular Septal Defect Device
3.1.17 Left Atrial Appendage Closure Device
3.1.18 Extracorporeal Membrane Oxygenation Machine
3.2 Fda Recalls
3.2.1 Maquet
3.2.2 Medtronic
3.2.3 Heartware Inc
3.3 Clinical Trials
3.3.1 Medtronic
3.3.2 St. Jude Medical
3.3.3 Abiomed
3.3.4 Heartware Inc

4. Off-Pump Coronary Artery Bypass Device Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Stabilizer Device Market
4.3.2 Positioner Market
4.3.3 Off-Pump Coronary Artery Bypass Accessories Market
4.3.3.1 Blower/Misters Market
4.3.3.2 Intracoronary Shunt Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

Companies Mentioned 

    --  Edwards Lifesciences
    --  St. Jude Medical
    --  Medtronic
    --  Maquet
    --  Abiomed
    --  HeartWare Inc.
    --  Sorin Group
    --  Terumo
    --  Abbott Laboratories
    --  Teleflex Medical
    --  Cardiac Assist
    --  AtriCure
    --  W.L. Gore
    --  SynCardia
    --  Boston Scientific
    --  Cryolife
    --  Berlin Heart
    --  Cardica
    --  Chase Medical
    --  Genesee Biomedical
    --  Karl Storz
    --  LifeNet Health
    --  Microline Surgical
    --  Novadaq
    --  On-X
    --  Saphena Medical
    --  SentreHeart
    --  Vitalitec

For more information about this report visit https://www.researchandmarkets.com/research/vb3wzm/united_states?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-off-pump-coronary-artery-bypass-devices-market-report-2017-2018-300574933.html

SOURCE Research and Markets